Futures tied to the 30-stock average shed 491 points, or 0.9%, as of 5 a.m. ET. S&P 500 futures were down by 0.4% ahead of ...

The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales ...

The march higher in 10-year Treasury yields toward 4.8% is still probably best viewed as a "normalization shock," in which ...

The Department of Energy has given grants to small battery tech companies. But the U.S. has a few years to do what took China ...

The Department of Energy is investing $500 million in U.S. battery companies to challenge China’s dominance. But with $24 ...

Australia plans to give social media users the option to switch off algorithm-based feeds in proposed legislation, serving as ...

CNBC’s Phil LeBeau and AerCap CEO Aengus Kelly join 'Squawk Box' to discuss the state of aircraft demand, growth outlook ...

Former U.S. Senator Heidi Heitkamp (D-N.D.) and former White House chief of staff Mick Mulvaney join 'Squawk Box' to discuss ...

CNBC's Diana Olick sits down with Nima Ghamsari, who launched his mortgage technology business Blend in the wake of the great ...

Loretta Mester, Princeton University Griswold Center for Economic Policy senior scholar and former Cleveland Fed president, ...

Roivant Sciences — Shares rallied 24% after the pharma company said Phase 2 trial results for subsidiary Pulmovant's ...

Kelly Ann Shaw, Partner at Akin, says U.S. Canada tensions remain a trade row, not a full trade war, with limited economic ...